+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      3H-Estradiol Distribution in Normal and Androgenized Female Rats Using an Improved Hypothalamic Dissection Procedure

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The distribution of radioactivity in control and neonatally androgenized adult rats was determined 48 h after ovariectomy and 1 h after an i.v. injection of either <sup>3</sup>H-estradiol or diethylstilbestrol (DES) + <sup>3</sup>H-estradiol. Control preoptic-anterior hypothalamic area (POA-AH) and median eminence-basal hypothalamus (ME-BH) concentrated radioactivity 9.6 and 7.9 times more, respectively, than did cortex. Tissue: cortex ratios ranged from 2.3 to 1.0 for other brain areas. Therefore, these two relatively small hypothalamic areas were reproducibly separated by gross dissection from the bulk of the hypothalamus and were shown to have a very high uptake of estradiol. Furthermore, DES inhibited uptake 79% in POA-AH and 85 % in ME-BH, demonstrating that the high uptake in these tissues was mediated by a limited capacity receptor system. DES also inhibited uptake in septum, dorsal hypothalamus and kidney. Radioactivity levels in cortex, hippocampus, brain stem, fat, liver and plasma were not affected by DES pretreatment, verifying that uptake in these tissues was mediated primarily by nonspecific factors. Androgenization did not significantly alter either total uptake or DES-blockable uptake in POA-AH, ME-BH, dorsal hypothalamus, septum or pituitary. The results show that it is possible for persistent-estrous, androgenized rats to have normal total and DES-blockable uptake of estradiol in pituitary and brain areas 1 h after <sup>3</sup>H-estradiol injection. Androgenization

          Related collections

          Author and article information

          S. Karger AG
          20 March 2008
          : 14
          : 2
          : 87-94
          Departments of Animal Physiology and Environmental Toxicology, University of California, Davis, Calif.
          122248 Neuroendocrinology 1974;14:87–94
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8


          Comment on this article